Last edition
News about "neurodegenerative disorders"
MerryLife Biomedical Reports Positive Phase I Data for Oral Alzheimer's Therapy TML-6
MerryLife Biomedical’s investigational oral therapy TML-6 demonstrated favourable safety and tolerability in Phase I, paving the way for a 210-patient global Phase II trial in early Alzheimer’s disease.
Neurodegenerative Disorders | 10/02/2026 | By News Bureau
Convergen Raises USD 10 Million Seed Funding to Advance TrimTAC Platform
Convergen has raised USD 10 million in seed funding from Qiming Venture Partners to speed up development of its TrimTAC platform—novel TRIM21-based bifunctional degraders—and advance its early pipeline targeting neurodegenerative and other high-need diseases.
Neurodegenerative Disorders | 09/12/2025 | By Akanki
Athira Pharma Announces Appointment of Javier San Martin as Chief Medical Officer
Athira Pharma, Inc. has appointed Javier San Martin, MD, as Chief Medical Officer.
Neurodegenerative Disorders | 16/04/2024 | By Aishwarya | 727
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy